NTRA
Price
$425.65
Change
+$15.30 (+3.73%)
Updated
Oct 5, 04:59 PM (EDT)
Capitalization
59.35B
37 days until earnings call
Intraday BUY SELL Signals
RCEL
Price
$13.22
Change
+$0.50 (+3.93%)
Updated
Oct 5, 04:59 PM (EDT)
Capitalization
360.92M
31 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NTRA vs RCEL

NTRA vs RCEL Comparison Chart in %
View a ticker or compare two or three
VS
NTRA vs. RCEL commentary
Oct 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a Buy and RCEL is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
NTRA vs RCEL: Fundamental Ratings
NTRA
RCEL
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
10100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
3534
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRA's Valuation (54) in the Biotechnology industry is in the same range as RCEL (62) in the null industry. This means that NTRA’s stock grew similarly to RCEL’s over the last 12 months.

NTRA's Profit vs Risk Rating (10) in the Biotechnology industry is significantly better than the same rating for RCEL (100) in the null industry. This means that NTRA’s stock grew significantly faster than RCEL’s over the last 12 months.

NTRA's SMR Rating (94) in the Biotechnology industry is in the same range as RCEL (100) in the null industry. This means that NTRA’s stock grew similarly to RCEL’s over the last 12 months.

RCEL's Price Growth Rating (34) in the null industry is in the same range as NTRA (35) in the Biotechnology industry. This means that RCEL’s stock grew similarly to NTRA’s over the last 12 months.

RCEL's P/E Growth Rating (100) in the null industry is in the same range as NTRA (100) in the Biotechnology industry. This means that RCEL’s stock grew similarly to NTRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTRARCEL
RSI
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
76%
Bearish Trend 15 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
COMPARISON
Comparison
Oct 06, 2026
Stock price -- (NTRA: $410.35 vs. RCEL: $12.72)
Brand notoriety: NTRA and RCEL are both not notable
NTRA represents the Medical Specialties, while RCEL is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: NTRA: 128% vs. RCEL: 82%
Market capitalization -- NTRA: $59.35B vs. RCEL: $360.92M
NTRA [@Medical Specialties] is valued at $59.35B. RCEL’s [@Medical/Nursing Services] market capitalization is $360.92M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.73B. The average market capitalization across the [@Medical Specialties] industry is $20.78B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRA’s FA Score shows that 1 FA rating(s) are green while RCEL’s FA Score has 0 green FA rating(s).

  • NTRA’s FA Score: 1 green, 4 red.
  • RCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, NTRA is a better buy in the long-term than RCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRA’s TA Score shows that 4 TA indicator(s) are bullish while RCEL’s TA Score has 4 bullish TA indicator(s).

  • NTRA’s TA Score: 4 bullish, 4 bearish.
  • RCEL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both NTRA and RCEL are a good buy in the short-term.

Price Growth

NTRA (@Medical Specialties) experienced а -0.54% price change this week, while RCEL (@Medical/Nursing Services) price change was +7.43% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.42%. For the same industry, the average monthly price growth was +6.10%, and the average quarterly price growth was +49.42%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.02%. For the same industry, the average monthly price growth was -4.09%, and the average quarterly price growth was -1.88%.

Reported Earning Dates

NTRA is expected to report earnings on Nov 11, 2026.

RCEL is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical Specialties (+0.42% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (+0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
NTRA
Daily Signal:
Gain/Loss:
RCEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WW14.741.02
+7.43%
WW International Inc
DSGN12.340.10
+0.82%
Design Therapeutics
DHT23.680.12
+0.51%
DHT Holdings
FWONA83.39-0.30
-0.36%
Liberty Media Corp
IFBD0.84-0.07
-7.85%
Infobird Co Ltd

RCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with SENS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then SENS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
+5.91%
SENS - RCEL
41%
Loosely correlated
-0.80%
NTRA - RCEL
30%
Poorly correlated
+0.46%
SGHT - RCEL
30%
Poorly correlated
-5.54%
VCYT - RCEL
29%
Poorly correlated
+3.67%
TWST - RCEL
29%
Poorly correlated
+0.33%
More